Trial ID or NCT#
This study will investigate the effects of rosiglitazone, a medicine commonly used to treat type 2 diabetes, on the utilization of glucose by the heart in patients with heart failure which is not due to heart attacks. The primary purpose of the study is to determine whether treatment with an insulin-sensitizing medication will improve the heart's ability to metabolize glucose (sugar).
Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Contact us to find out if this trial is right for you.
Michael B Fowler, MB